Lee 1996.
Methods | Allocation: randomised ‐ divided into 3 groups randomly Blindness: not mentioned, assume open‐label |
Participants | Diagnosis: people with chronic schizophrenia, residual type according to DSM‐III‐R and had predominant negative symptoms evaluated by PANSS |
Interventions | Haloperidol + carbamazepine or haloperidol + valproate or haloperidol only |
Outcomes | Mental states: BPRS, PANSS, CGI Depression: HRDS Adverse events: SAS |
Notes |